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Toxicity of tryptophan manganese(I) carbonyl (Trypto-CORM), 
against Neisseria gonorrhoeae  
Jonathan S. Ward,
a,b
 Rebecca Morgan,
b
 Jason M. Lynam,
a
 Ian J. S. Fairlamb
a,c
 and James W. B. 
Moir
b
*
The potential for carbon monoxide-releasing molecules (CO-RMs) 
as antimicrobials represents an exciting prospective in the fight 
against antiobiotic resistance. Trypto-CORM, a tryptophan-
containing manganese(I) carbonyl), is toxic against E. coli following 
photo-activation. Here, we demonstrate that Trypto-CORM is 
toxic against Neisseria gonorrhoeae in the absence of 
photoactivation. Trypto-CORM toxicity was reversed by the high 
CO affinity globin leg-haemoglobin (Leg-Hb), indicating that the 
toxicity is due to CO release. Release of CO from Trypto-CORM in 
the dark was also detected with Leg-Hb (but not myoglobin) in 
vitro. N. gonorrhoeae is more sensitive to CO-based toxicity than 
other model bacterial pathogens, and may serve as a viable 
candidate for antimicrobial therapy using CO-RMs. 
Introduction 
Carbon monoxide (CO) is well known as a toxic gas, ca. 350-
400 ppm, which is responsible for over a third of lethal 
poisonings in the developed world.
1
 The toxicity of CO arises as 
a consequence of binding to haemoglobin, and other metal 
centres in living systems, particularly cytochrome c oxidase.
2
 
However, CO is a normal part of metabolism during haem 
turnover,
3
 and has been shown to display therapeutic 
potential in a variety of situations, such as cardiovascular 
disease, inflammation and organ transplantation.
4,5,6
  
 CO is difficult to selectively administer directly as a gas, and 
thus many chemical CO-releasing molecules (CO-RMs) have 
been developed, and their potential as therapeutic agents 
examined.
7
 A number of recent studies have investigated the 
validity of using CO-RMs as antimicrobials against a variety of 
bacteria including Escherichia coli (E. coli), Staphylococcus 
aureus (S. aureus), Pseudomonas aeruginosa, Helicobacter 
pylori and Campylobacter jejuni.
8,9,10,11,12,13
 The targets of CO-
RM action include the respiratory haem-copper oxidases,
10
 but 
CO-RM toxicity may also be mediated by reactive oxygen 
species.
14
 
 CO-RMs typically consist of a metal centre bearing multiple 
CO ligands, and an additional multidentate ligand for the 
tuning of any required physical properties.
7,15
 The CO can be 
released thermally, photolytically or via a hydrolytic (e.g. 
enzyme-triggered or solvolysis) mechanism.
16
 
 
 
Figure 1. Selected photo-activated CO-RMs. 
 
CO-RMs that release CO in response to photoirradiation are 
referred to as PhotoCO-RMs  W selected examples were 
reported by Bischof et al.
17
, Kretschmer et al.
18
, Pfeiffer et 
al.
19
, Rimmer et al.
20
 and  Ward et al.
21
 These particular 
PhotoCO-RMs have been shown to inhibit E. coli growth 
following photoirradiation. This includes irradiation of 
[Mn(CO)3(tpa-ʃ3N)]Br at 365 nm, reported by Nagel et al.22, or 
following irradiation of Mn(CO)3(CH3CN)(Tryptophan) ( ‘Trypto-
CORM ?) at 400 nm.23 In the latter case it was demonstrated 
that the effect of CO-RM was cytotoxic, with > 99 % of E. coli 
cells being killed following irradiation of the CO-RM.
23
  
 Here we have investigated the toxicity of Trypto-CORM 
against Neisseria gonorrhoeae which is a globally important 
bacterial pathogen. N. gonorrhoeae is the causative agent of 
sexually transmitted infection gonorrhoea, and has recently 
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been identified as a particular danger due to the emergence of 
hyper-resistant lineages, resistant to the major frontline 
antibiotics.
24,25,26
. New therapies against N. gonorrhoeae are 
urgently required, and we set out to establish whether CO-
RMs might be effective in this respect. As controls, we also 
investigated the sensitivity of Trypto-CORM against two other 
model bacterial species, previously used in CO-RM research, E. 
coli and S. aureus.  During this work it has been shown that 
Trypto-CORM, a thermally-stable metal carbonyl compound 
that only releases CO efficiently following irradiation, caused 
CO-dependent toxicity in the dark (thermal release of CO) 
against target pathogenic bacterial species, specifically N. 
gonorrhoeae. 
Results and Discussion 
Our studies on Trypto-CORM are herein divided into four 
sections, followed by a discussion of the results and analysis.  
 
Trypto-CORM is toxic to Neisseria gonorrhoeae, in 
the dark: Treatment of N. gonorrhoeae with Trypto-CORM 
prevented growth (Fig. 2, panel A) and resulted in a loss of > 
99 % cellular viability in the dark (Fig. 2, panel B). These 
experiments were conducted with fresh (1 to 2 days old) plate 
cultures. It was not possible to examine the impact of viability 
of N. gonorrhoeae over longer-term experiments as carried 
out for E. coli and S. aureus (see below), because N. 
gonorrhoeae survival on plates is limited to only a few days. 
The concentration of Trypto-CORM sufficient to reduce 
viability by 50 % (IC50) was 22 µM (Fig. 2, panel C).  
 The toxicity of 100 µM Trypto-CORM against N. 
gonorrhoeae can be partially reversed by treatment with a 
sub-stoichiometric concentration of Leg-Hb (22 µM). Leg-Hb 
halts the decline in OD600 over time that is observed in 
growth curves with Trypto-CORM (Fig. 2, panel A), and also 
results in a higher recovery of viable numbers of N. 
gonorrhoeae colony forming units, than following Trypto-
CORM treatment in the absence of Leg-Hb (Fig. 2, panel B). 
Nonetheless, Trypto-CORM continues to exert toxicity against 
N. gonorrhoeae even in the presence of the high affinity CO 
scavenger Leg-Hb, indicating that N. gonorrhoeae is exquisitely 
sensitive to CO-releasing compounds. Deoxy-myoglobin is 
unable to rescue the toxicity of Trypto-CORM towards N. 
gonorrhoeae (not shown).   
 
Slow CO release in the dark from Trypto-CORM can be 
captured using leg-haemoglobin: Trypto-CORM releases CO 
readily following irradiation, but appears quite stable in the 
dark, and has thus been termed a photo-activatable CO-RM. 
The demonstration that Leg-Hb is able to rescue N. 
gonorrhoeae from Trypto-CORM toxicity in the dark indicates 
that Trypto-CORM is able to release physiologically significant 
levels of CO under these conditions. To explore this further we 
examined the capacity of Leg-Hb to scavenge CO released from 
Trypto-CORM in vitro.   
 
 
 
Figure 2. Impact of Trypto-CORM on growth and viability of N. gonorrhoeae. Panel A, 
growth of N. gonorrhoeae MS11 in RPMI + YAL + 100 µM Trypto-CORM (filled 
triangles), RPMI + YAL + 0.5 % DMSO (filled circles), RPMI + YAL + 100 µM Trypto-CORM 
+ 22 µM Leg-Hb (open triangles) and RPMI + YAL + 0.5 % DMSO +22 µM Leg-Hb  (open 
circles). Panel A data are representative of at least three biological replicates.  Panel B, 
viable numbers (colony forming units per ml (cfu/ml)) of N. gonorrhoeae at inoculation, 
after 4 h growth in the presence of 100 µM Trypto-CORM after 4 h growth in the 
absence of CORM, and after 4 h growth in the presence of 100 µM Trypto-CORM + 22 
µM Leg-Hb. Panel B results show the mean and standard deviation from at least four 
ďŝŽůŽŐŝĐĂů ƌĞƉůŝĐĂƚĞƐ ?^ƚƵĚĞŶƚ ?Ɛ ƚ-tests were performed to assess difference in viability 
between treatments. ** indicates P < 0.001. * indicates P < 0.05. Panel C, effect of 
[Trypto-CORM] on N. gonorrhoeae viability. Viability was tested after 4 h with Trypto-
CORM at a range of concentrations and the IC50 calculated as 21 ± 2 µM from a logistic 
fit to the data. 
 
Leg-Hb has a high affinity for O2 (Kd = 6.4 nM) and for CO (Kd = 
0.9 nM) compared to other globins, such as horse myoglobin 
(Mb) (Kd O2 = 780 nM; Kd CO = 34 nM).
27,28
. In previous work
23
 
it was shown using a myoglobin-based spectroscopic assay
29
 
that Trypto-CORM does not release significant amounts of CO 
ƵŶƚŝůŝƌƌĂĚŝĂƚĞĚ ?dŚĞĐŚĂŶŐĞŝŶƚŚĞɲ ?ɴƌĞŐŝŽŶĨŽƌŵǇŽŐůŽďŝŶŝŶ
the presence of Trypto-CORM is shown in Figure 3 (panel A). 
Very small changes in the visible spectral features are 
observable prior to irradiation, indicating that some Mb-CO 
forms in the absence of irradiation. This is seen more clearly in 
Figure 3, panel B which shows the difference spectra for time 
points after adding Trypto-CORM compared to time 0. Over 45 
minutes incubation, 5 % of ferrous deoxy-Mb is converted to 
the Mb-CO form. No spectral change occurs to oxygenated 
myoglobin (Mb-O2) in the presence of Trypto-CORM over a 2 
hour period (not shown), indicating that the slow release of CO 
from Trypto-CORM is unable to displace ligated O2.  
B**
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Figure 3. Spectroscopic analysis of Trypto-KZDƌĞĂĐƚŝŽŶǁŝƚŚŵǇŽŐůŽďŝŶĂŶĚůĞŐŚĂĞŵŽŐůŽďŝŶ ?WĂŶĞů ?ƐƉĞĐƚƌĂŽĨƚŚĞɲ ?ɴƌĞŐŝŽŶŽĨ ? ?A?DŚŽƌƐĞŵǇŽŐůŽďŝŶ  in the presence of 100 
µM Trypto-CORM. Deoxy-myoglobin is shown in dark red. Spectra were taken every 10 minutes in the dark (red to orange, solid lines), and then with bursts of 4 min. irradiation at 
400 nm (2.4 W) (green to blue, dashed lines). Saturated carbonmonoxy form of myoglobin is shown in black. To enable better visualisation of the formation of Mb-CO in the 
presence of Trypto-KZDŝŶƚŚĞĚĂƌŬ ?ƉĂŶĞůƐŚŽǁƐĚŝĨĨĞƌĞŶĐĞƐƉĞĐƚƌĂŽĨƚŚĞɲ ?ɴƌĞŐŝŽŶŽĨŵǇŽŐůŽďŝŶĂƚ ?ŵŝŶƵƚĞŝŶƚĞƌǀĂůƐĨŽůůŽǁŝŶŐƚŚĞĂĚĚ ition of Trypto-CORM compared to 
the spectrum at time zero, in the absence of irradiation. Spectra displayed using rainbow colours from red to blue with time.  WĂŶĞů  ? ƐƉĞĐƚƌƵŵ ƐŚŽǁŝŶŐ ƚŚĞ ɲ ?ɴ ƌĞŐŝŽŶ ŽĨ
leghaemoglobin in the presence of Trypto-CORM, in the absence of irradiation. Spectra were taken at 5 min. intervals for 55 min. Spectra displayed using rainbow colours from red 
to blue with time, as the spectrum shifts from the oxy- towards the carbonmonoxy-form. After 55 min.  ca. 50 % of Leg-HB has assumed the carbonmonoxy form  ‘>ĞŐ-Hb-K ? with 
a pseudo first order exponential rate constant of k = 0.1055 min
-1
. Panel D, a scheme showing the rates of reaction of myoglobin and leghaemoglobin with CO and O2 (data taken 
from (Imamura & Riggs, 1972; Wittenberg et al., 1965)). 
 
The reaction of Leg-Hb (as prepared in the oxy form, Leg-Hb-
O2) with Trypto-CORM was analysed by measuring the changes 
ŝŶ ƚŚĞ ǀŝƐŝďůĞ ƐƉĞĐƚƌƵŵ ŝŶ ƚŚĞ ɲ ?ɴ ƌĞŐŝŽŶ ďǇ hs ?sŝƐ
spectroscopy. Significant conversion of Leg-Hb-O2 to Leg-Hb-
CO occurs over a 55 min. incubation period (Fig. 3, panel C), 
such that at this point Leg-Hb is 50 % saturated with CO. The 
rate constant for conversion of Leg-Hb-O2 to Leg-Hb-CO is 
0.106 min
-1
, consistent with an effective steady state [CO] = 
0.13 nM in the presence of 100 µM Trypto-CORM (see Fig. 3, 
panel D). The relatively slow kon CO rate for Mb compared to 
Leg-Hb (0.5 µM
-1
,s
-1
 c.f. 13.5 µM
-1
.s
-1
)
28,30
 is sufficient to 
explain the slow rate of conversion of Mb to Mb-CO. koff O2 for 
Leg-Hb is fast (1 s
-1
) compared to the observed rate of 
formation of Leg-Hb-CO from Leg-Hb-O2 in the presence of 
Trypto-CORM (0.0018 s
-1
), explaining why Leg-Hb is able to 
scavenge CO from Trypto-CORM even in the presence of 
oxygen.  This ability of Leg-Hb to scavenge CO from Trypto-
CORM, indicates that this CORM does act as a significant 
source of CO in the dark, but that this can only be detected 
with a very high affinity CO binding sink. The ability of Leg-Hb 
to abstract very low concentrations of CO from a system, even 
when initially present as the oxygen bound form underpins its 
ability to scavenge CO in the biological systems above, in 
which oxygen is readily available.  
 
Toxicity of Trypto-CORM against E. coli requires irradiation 
and depends on culture age: The toxicity of Trypto-CORM 
against E. coli has been previously reported.
23
 Here we extend 
the previous study to confirm that Trypto-CORM toxicity 
against E. coli requires irradiative CO release, and that the 
effect depends on E. coli culture age. Trypto-CORM alone had 
no inhibitory effect on E. coli growth, but the combination of 
Trypto-CORM and irradiation at 400 nm caused a cessation of 
growth (Fig. 4, Panels A-C). The recovery of growth depends on 
the age of the plate culture used. Growth resumed following 
CO-RM irradiation in a 6 day old plate culture (Fig. 4, Panel A), 
but for a 14 day culture, growth was not seen over the 8 hour 
incubation (Fig. 4, Panel C). To test whether the effect of 
Trypto-CORM is cytostatic or cytotoxic, we determined viable 
counts before (at t= 0) and after irradiation (at t = 4 h) 
following liquid culture growth from a 14 day E. coli plate 
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culture (Fig. 4, panel D). Trypto-CORM is cytotoxic, killing 
greater than 99 % of the population following irradiation at 
400 nm.   
 
 
Figure 4. Impact of Trypto-CORM on growth of E. coli. Growth of E. coli was followed by 
measuring OD600 over time.  Panels A-C show growth curves of E. coli cultured from 
plates that were 6 days old (panel A), 8 days old (panel B) and 14 days old (panel C). 
Growth was carried out in LB + 100 µM Trypto-CORM (black triangles) and LB + Trypto-
CORM with irradiation (400 nm, 2.4 W, 68 min., started at 1 h after inoculation) (grey 
triangles), LB + 0.5 % DMSO (black circles) and LB + 0.5 % DMSO with irradiation (grey 
circles). Panel D shows the viability of E. coli before (time 0) and after (time = 4 h) 
treatment with Trypto-CORM and irradiation at 400 nm in the 14 day old E. coli culture 
used in panel C.  
 
Cytotoxic and cytostatic effect of Trypto-CORM against S. 
aureus in the dark: The toxicity of Trypto-CORM against Gram 
positive pathogenic bacterium S. aureus was also tested. 
Treatment with either CO-RM or irradiation at 400 nm 
prevents growth of S. aureus (Fig. 5, panel A). Trypto-CORM 
and 400 nm irradiation in combination kills 95 % of bacteria 
cultured from a 1 day old S. aureus plate culture (Fig. 5, panel 
B). With Trypto-CORM in the absence of irradiation there is a 
cytostatic effect with these cultures (Fig. 5, panel B).  
 To test whether S. aureus culture age had an impact on the 
effectiveness of Trypto-CORM, the viability of S. aureus 
cultures 6 hours after treatment with Trypto-CORM (without 
irradiation) was determined. The viability of Trypto-CORM 
treated cultures drops  by > 99.9 % in cultures made from 
plates that were > 5 days old, indicating that Trypto-CORM 
becomes cytotoxic to S. aureus in an age-dependent way (Fig. 
5, panel D). To test whether the toxicity of Trypto-CORM could 
potentially be reversed by scavenging released CO, cultures 
were supplemented with 22 µM Leg-Hb. LegHb treated 
cultures retained viability (Fig. 5, panel D), but did not grow 
(Fig. 5, panel C). The addition of myoglobin (Mb) had no 
rescuing effect on the viability of S. aureus in the presence of 
Trypto-CORM (not shown).  
 
Further Discussion: This is the first experimental analysis of 
the effect of CO-releasing molecules on the important human 
pathogen Neisseria gonorrhoeae. We find that under the 
conditions tested, Trypto-CORM is highly toxic to N. 
gonorrhoeae, even in the absence of irradiative treatment that 
would cause a more efficient release of CO.  N. gonorrhoeae is 
of particular interest due to recent occurrences of N. 
gonorrhoeae completely resistant to frontline antibiotics in the 
clinic.
24,25,26
 Previous work has been extended in order to show 
that the Trypto-CORM is toxic against S. aureus, as well as E. 
coli. Like with N. gonorrhoeae, Trypto-CORM is able to display 
toxicity against S. aureus in the absence of irradiation.  In both 
cases, it has been confirmed that even in the absence of 
irradiation, the toxic effect of Trypto-CORM is at least partially 
due to CO release itself (as shown by the ability of Leg-Hb to 
rescue the bacteria from the toxicity of Trypto-CORM). In N. 
gonorrhoeae experiments, Leg-Hb is not able to completely 
reverse the toxicity due to Trypto-CORM. Either, N. 
gonorrhoeae is sensitive to concentrations of CO below the 
concentration which can be effectively scavenged by Leg-Hb, 
or, Trypto-CORM is toxic via independent mechanisms in 
addition to CO release, which are specific to certain bacteria. 
The Leg-Hb treatment of S. aureus reverses the toxic effect of 
Trypto-CORM completely, but the cytostatic effect remains.  
 With both E. coli and S. aureus, a distinctive effect of 
culture age is observed. Cultures that have been stored for a 
longer time are more sensitive to Trypto-KZD ƚŚĂŶ  “ĨƌĞƐŚ ?
bacterial cultures. The number of viable cells present in a 
bacterial inoculum is not sufficient to explain this effect, since 
when the inoculum from a fresh culture was diluted to give the 
same viable number as in the inocula from older cultures 
growth recovered from the freshly cultured bacteria but not 
the older cultures. The mechanistic basis for this age-
dependence of Trypto-CORM toxicity remains to be explored, 
but might be due to a depletion in the number of active haem-
copper oxidase complexes in near-dormant cells. The age-
dependent effect is of some potential interest, since persistent 
bacteria during infection are frequently slow growing or 
dormant, and it is these bacteria that are often particularly 
recalcitrant to antibiotic treatment, an example being reported 
by Rittershaus et al. in 2013.
31
. A novel antimicrobial that is 
able to target bacteria in a dormant physiological state could 
be a useful addition to the antibiotic arsenal. 
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Figure 5. Impact of Trypto-CORM on growth and viability of S. aureus. Growth of S. aureus was followed by measuring OD600 over time. Panel A, the growth of S. aureus 8325-4 in 
LB + 100 µM Trypto-CORM (black triangles) and LB + Trypto-CORM with irradiation  (400 nm, 2.4 W, 68 min., started at 1 h after inoculation) (grey triangles), LB + 0.5 % DMSO 
(black circles) and LB + 0.5 % DMSO with irradiation (grey circles). Panel B, the impact of irradiation + CORM on viability of 1-4 day-old cultures of S. aureus in LB + 100 µM Trypto 
CORM before treatment and after irradiation (CORM + light) (400 nm, 2.4 W, 68 min., started at 1 h after inoculation), and after a prolonged (4  W 7 h) incubation in the absence of 
irradiation (CORM  W light). 95 % of the viability was lost following irradiation, but in the absence of irradiation there is little loss of viability. Panel C, growth of S. aureus in LB + 100 
µM Trypto-CORM (black triangles), LB + 0.5 % DMSO (black circles) and LB + 100 µM Trypto-CORM + 22 µM Leg-Hb (white diamonds). Panel D, viability of S. aureus following 
treatment with Trypto-CORM in the dark. X-axis indicates the number of days since the culture was grown. S. aureus was suspended to an initial OD600 = 0.05 and incubated with 
100 µM Trypto-CORM for a prolonged (4 - 6 h) incubation, at which point suspensions were plated out to determine viable counts (black bars). Trypto-CORM has a > 99 % cytotoxic 
effect on cultures over 7 days old. Inclusion  of 22 µM Leg-Hb (grey bars) rescues cultures from toxicity of 100 µM Trypto-CORM.  
 
 
The finding that Trypto-CORM is able to function in 
physiologically relevant CO release in the dark is of further 
interest. This offers a new strategy for targeting the CO 
released by this molecule, and other molecules like it, to high 
affinity CO binding sites within particular bacteria. This could 
provide a selectivity to the infectious agent and added safety 
to the host (eukaryotic cells in culture have been shown to be 
insensitive to [Trypto-CORM] of 100 µM in the absence of 
photoirradiation.
23
  
 A novel dimension to our work described here is the 
development of leghaemoglobin as a useful probe for 
spectroscopic analysis of CO in biology. Leg-Hb enables us to 
assess the effect of a lower range of CO concentrations than is 
possible using other globins, particularly myoglobin which has 
been used as the routine work-horse for probing CO release 
from CO-RMs to date.
29
 
 The comparative analysis of Trypto-CORM against different 
bacterial species shows that different bacteria have very 
different sensitivities to CO release from this molecule, with S. 
aureus and N. gonorrhoeae considerably more sensitive, since 
E. coli is completely insensitive to Trypto-CORM except after 
the rapid release of CO following photoirradiation.  It will be of 
interest to explore the sensitivity of other potential target 
microorganisms and identify the molecular basis for this 
differential sensitivity in order to rationally design future CO-
based antimicrobials against specific pathogens. 
Conclusions 
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The potential for CO-RMs as antimicrobials is promising for 
influencing the growth of a range of bacterial species. We 
conclude that Trypto-CORM is toxic against Neisseria 
gonorrhoeae in the dark under thermal/cellular control (i.e. 
absence of photoactivation). The toxicity of Trypto-CORM was 
reversed by the high CO affinity globin leg-haemoglobin (Leg-
Hb), confirming that the toxicity is due to the release of CO. 
Release of CO from Trypto-CORM in the dark was also 
detected with Leg-Hb (but not myoglobin) in vitro. It is of 
further interest to consider that leg-haemoglobin should be 
used more widely in CORM / CO research, due to its very high 
CO affinity making it a valuable tool for accessing the 
physiological effects of CO at low concentrations. In our 
previous work we have found that Trypto-CORM is toxic to E. 
coli only following photoactivation, whereas S. aureus was 
sensitive to CO from Trypto-CORM following irradiative release 
and, to a certain extent, in the dark. It is evident that N. 
gonorrhoeae is more sensitive to CO-based toxicity than other 
model bacterial pathogens, and we suggest that it is an 
appropriate candidate for antimicrobial therapy using CO-
RMs.
32,33
 
Experimental section 
 
Bacterial strains and culture conditions: Specialist bacterial 
media and components of media were obtained from Oxoid. 
Other chemicals were obtained from Sigma-Aldrich, except 
where stated otherwise. Neisseria gonorrhoeae MS11 was 
stored in 50% glycerol: 50 % Mueller Hinton broth at -80 °C. 
Stocks were streaked onto Columbia agar plus 5% defibrinated 
horse blood and grown and maintained (for up to three days) 
at 37 °C in a 95 % air: 5 % CO2 atmosphere. Liquid cultures 
were set up from these plates into liquid media RPMI (Gibco) 
containing Yeast Autolysate Supplement. The supplement 
powder was dissolved in 15 ml sterile water and 1.5 ml liquid 
supplement was added to 50 ml of RPMI medium. Cultures 
were grown in 3 ml of media in 8 ml Bijou tubes at 37 °C and 
sampled as described above for E. coli.  
 Escherichia coli W3110 was cultured in Lysogeny broth (LB; 
10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl) in liquid media, 
and on plates supplemented with 1.5 % bacteriological agar. 
Streak plates were grown for 16 hours at 37 °C, from glycerol 
ƐƚŽĐŬƐŵĂŝŶƚĂŝŶĞĚĂƚAL ? ?°C. Plates were subsequently stored 
at 4 °C for up to one month. Liquid cultures were inoculated to 
a starting OD of 0.05 (except where stated otherwise) and 
cultured with shaking at 100 rpm in 3 ml of media in 8 ml Bijou 
tubes at 37 °C. 300 µl aliquots were withdrawn hourly in order 
to measure optical density at 600 nm (OD600) using a Jenway 
6305 spectrophotometer and/or make serial dilutions in order 
to determine the number of viable bacteria (colony forming 
units; cfu) per ml of culture. 
 Staphylococcus aureus 8325-4 was cultured and 
maintained as described for E. coli.  
 
Preparation and application of Trypto-CORMs Trypto-CORM 
was prepared as described previously.
23
 The CORM was 
dissolved in DMSO to generate a 20 mM stock solution. This 
was diluted 200x into the growth medium to give a working 
Trypto-CORM concentration of 100 µM. 0.5 % DMSO was 
added to media as a control. The irradiation of Trypto-CORM 
was carried out using a customised LED arrangement (as 
described by (Ward et al., 2014)) in which each LED  having a 
power of  ? ? ? t ? /ƌƌĂĚŝĂƚŝŽŶ ǁĂƐ ĚĞůŝǀĞƌĞĚ ŝŶ  “ ? ŵŝŶƵƚĞ ŽŶ ?  ?
ŵŝŶƵƚĞ ŽĨĨ ? ĐǇĐůĞƐ ƚŽ ƉƌĞǀĞŶƚ ƚŚĞ > ĨƌŽŵ ŐĞƚƚŝŶŐ ŚŽƚ ?
beginning 1 h post-inoculation of microbiological cultures. 
Irradiation in these experiments was typically carried out for a 
total of 68 minutes (17 full cycles), using a 400 nm LED. Dark 
controls were maintained in culture vessels wrapped in 
aluminium foil. 
 
Preparation of leghaemoglobin: Leghaemoglobin from 
Soybean was purified following its heterologous expression in 
E. coli, using a previously described expression vector (Jones et 
al., 1998
34
). E. coli > ? ?  ?ʄ ? ? ĐŽŶƚĂŝŶŝŶŐ ƚŚĞ Ɖd ? ?Ă
derivative containing the Soybean leghaemoglobin gene was 
grown overnight at 37 °C on an LB agar plate with 100 µg.ml
-1
 
ampicillin. A single colony was transferred to 5 ml of LB media 
with 100 µg.ml
-1
 ampicillin in a Sterilin tube. This was grown at 
37 °C on an orbital shaker with 225 rpm rotation for 6 hours. 
The 5 ml culture was then transferred to 635 ml of auto 
induction medium in a 2 L baffled conical flask (following the 
procedure of Bonsor et al.
35
) and grown at 37 °C overnight 
with shaking at 120 rpm. The culture was harvested by 
centrifugation at 5000 rpm for 15 min. at 4 °C. The medium 
was discarded from the red pellet of cells which was 
subsequently re-suspended in 35 ml 50mM Tris/HCl (pH 9). 
The suspension of cells was then sonicated in a 50 ml Falcon 
tube on ice using a Misonix 3000 sonicator with 10 s on/off 
cycles for a total sonication time of 3 minutes. Cell debris was 
then removed by two centrifugation cycles at 11000 rpm for 
15 minutes (4 °C). Supernatant was transferred to a new 
Falcon tube after the first centrifugation to remove most of 
the debris. 
 The protein was purified on a 1.5 cm diameter anionic 
exchange column using DEAE sepharose CL6B, then loaded on 
to the column and was washed with 50 mM Tris/HCl (pH 9) 
until the red band indicative of the protein was running very 
close to the bottom of the column. The protein was then fully 
eluted using a gradient of 30 mM to 500 mM NaCl in 20 mM 
K2HPO4 pH 7. 5 ml eluent fractions were retained, and protein 
purity was confirmed by 15 % SDS-PAGE. The protein solution 
was concentrated 10 fold using a Vivaspin 20 MWCO (PES) 
5,000 Falcon tube. The resultant protein solution was desalted 
by diluting 10 fold with 10 mM Tris/HCl pH 7.4 and 
concentrating the new solution with the Vivaspin tube 10 fold. 
This dilution with Tris buffer was performed once more to 
dilute any salt in the solution by a total 100 fold. The protein 
was divided into aliquots and was stored aƚ AL ? ?°C and was 
used within 2 months of preparation.  
 
Spectroscopic methods: UV-Visible spectroscopy of myoglobin 
(horse heart Mb, obtained from Sigma) and Leg-Hb was carried 
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out on a JASCO V-560 spectrophotometer. Data was analysed 
in accordance with the protocol we used previously.
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